(Q51496434)

5 April 2018

title

Associations between ADRB1 and CYP2D6 gene polymorphisms and the response to β-blocker therapy in hypertension. (English)

1 reference

5 April 2018

author name string

Dingchang Wu

1

1 reference

5 April 2018

Ganyang Li

2

1 reference

5 April 2018

Maoqing Deng

3

1 reference

5 April 2018

Wei Song

4

1 reference

5 April 2018

Xiaohua Huang

5

1 reference

5 April 2018

Xiaoru Guo

6

1 reference

5 April 2018

Zhengzheng Wu

7

1 reference

5 April 2018

Shiyang Wu

8

1 reference

5 April 2018

Jiasen Xu

9

1 reference

5 April 2018

publication date

30 March 2015

1 reference

5 April 2018

Journal of International Medical Research

published in

1 reference

5 April 2018

volume

43

1 reference

5 April 2018

issue

3

1 reference

5 April 2018

page(s)

424-434

1 reference

5 April 2018

Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Trends in the treatment of hypertension from the perspective of traditional chinese medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

21 January 2018

Genes and hypertension

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Effects of polymorphisms in β1-adrenoceptor and α-subunit of G protein on heart rate and blood pressure during exercise test. The Finnish Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Effects of polymorphism of the beta(1) adrenoreceptor and CYP2D6 on the therapeutic effects of metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Gly389Arg polymorphism of β1-adrenergic receptor is associated with the cardiovascular response to metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Role of CYP450 in pharmacokinetics and pharmacogenetics of antihypertensive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Effect of the CYP2D6 genotype on metoprolol metabolism persists during long-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Expanding role of pharmacogenomics in the management of cardiovascular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacokinetics and systemic effects of ophthalmic timolol. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Relation of ADRB1, CYP2D6, and UGT1A1 polymorphisms with dose of, and response to, carvedilol or metoprolol therapy in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

The expression level of myocardial β1-adrenergic receptor affects metoprolol antihypertensive effects: a novel mechanism for interindividual difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Impact of β(1)- and β(2)-adrenergic receptor gene single nucleotide polymorphisms on heart rate response to metoprolol prior to coronary computed tomographic angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Association of common polymorphisms in β1-adrenergic receptor with antihypertensive response to carvedilol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

A frequent gene polymorphism affecting the heart-rate response to carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Genetic factors are relevant and independent determinants of antihypertensive drug effects in a multiracial population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514563151

21 January 2018

Identifiers

DOI

10.1177/0300060514563151

1 reference

5 April 2018

1 reference

5 April 2018